Skip to content
HOOGResearch & Advisory

Healthcare & Life Sciences

Pricing and Market Access for a Surgical Device

Defining a price corridor and access strategy for launching a premium surgical device.

Example engagement
Client
International medical device company
Industry
Healthcare & Life Sciences
Geography
India
Duration
7 weeks
Capabilities
Pricing Research, Market Entry & GTM

Research design at a glance

How the work is structured

India · 7 weeks

  1. 1

    Payer interviews

    Insurers and third-party administrators.

  2. 2

    Procurement and surgeon interviews

    Private and public hospital decision-makers.

  3. 3

    Price sensitivity research

    Acceptable price ranges by segment.

  4. 4

    Competitive price benchmarking

    Tender and list price review.

Qualitative depth

Interviews, groups & observation

  • Payer interviews~10
  • Hospital interviews~25

Sample sizes are indicative of a typical design for this type of question; real engagements are scoped to the decision.

01

Client context

The company was preparing to launch a device priced at a premium to existing alternatives.

02

Business challenge

Pricing had to balance hospital budgets, insurance coverage, patient payments and competitor price points.

03

Research objective & questions

Recommend a price corridor, access approach and value story for each buyer type.

  • How price-sensitive are hospitals, insurers and patients?
  • How do insurance and government schemes affect uptake?
  • What value story will resonate with each buyer?
  • How do competitor prices compare?

04

Methodology & approach

Payer interviews
Insurers and third-party administrators.
Procurement and surgeon interviews
Private and public hospital decision-makers.
Price sensitivity research
Acceptable price ranges by segment.
Competitive price benchmarking
Tender and list price review.

05

Sample & geography

  • ~10 payer interviews
  • ~25 hospital interviews
  • Geography — India

06

Key findings

  • Premium pricing was acceptable in private tertiary hospitals with outcome evidence.
  • Insurance package rates constrained uptake in mid-tier hospitals.
  • Surgeons valued procedure time savings, which could support a value story.
  • Public tenders required a separate product configuration.

07

Business implications

  • Launch in private tertiary hospitals with outcome evidence.
  • Engage insurers on package rate inclusion.
  • Develop a tender-specific configuration.

08

Outcome

The company received a segment-level price corridor, access roadmap and value dossier inputs.

Example engagement — Shows how Hoog approaches this type of question. Not a specific client project. Findings are directional.

Start a conversation

Facing a similar question?

Tell us about the decision you are facing. We will come back with a clear view of how research can help — and what it would take.